What is Protagonist Therapeutics's PP&E (net)?

Protagonist Therapeutics (PTGX) reported PP&E (net) of $3.78M in Q1 2026.

How has Protagonist Therapeutics's PP&E (net) changed year-over-year?

Protagonist Therapeutics's PP&E (net) increased by 7.0% year-over-year, from $3.53M to $3.78M.

What is the long-term trend for Protagonist Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Protagonist Therapeutics's PP&E (net) has grown at a 21.4% compound annual growth rate (CAGR), from $1.46M to $3.86M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Protagonist Therapeutics PTGX PP&E (Net)

PP&E (Net) at other companies

Bristol-Myers SquibbBMY

$7.66B+6.2%

Eli LillyLLY

$26.54B+43.7%

AmgenAMGN

$8.22B+23.0%

IncyteINCY

$720.17M-5.9%

AbbVieABBV

$5.69B+8.6%

Apogee Therapeutics, Inc.APGE

——

Segments

By geography

See full

AU$40K-14.9%

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's PP&E (net)?: Protagonist Therapeutics (PTGX) reported PP&E (net) of $3.78M in Q1 2026.
How has Protagonist Therapeutics's PP&E (net) changed year-over-year?: Protagonist Therapeutics's PP&E (net) increased by 7.0% year-over-year, from $3.53M to $3.78M.
What is the long-term trend for Protagonist Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Protagonist Therapeutics's PP&E (net) has grown at a 21.4% compound annual growth rate (CAGR), from $1.46M to $3.86M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.